Table 1. Potential applications of different ‘omic technologies to a complex trait like ARDS.
For each application, the tested analyte is named and the most likely potential applications are highlighted with an X.
Analyte Field |
Infer Mechanism |
Candidate Marker Validation |
Candidate Marker Discovery |
Identify Subclasses |
Risk Stratify |
Improve Diagnosis |
Identify Therapeutic Targets |
---|---|---|---|---|---|---|---|
| |||||||
DNA | x | x | x | x | x | ||
Genomics | |||||||
| |||||||
DNA | x | x | x | x | |||
methylation or acetylation | |||||||
Epigenomics | |||||||
| |||||||
mRNA | x | x | x | x | x | x | |
- miRNA | |||||||
- ncRNA | |||||||
Transcriptomics | |||||||
| |||||||
Proteins | x | x | x | x | x | x | x |
Proteomics | |||||||
| |||||||
Metabolites | x | x | x | x | x | x | x |
Metabolomics | |||||||
| |||||||
Systems | x | x | x | x | |||
Interactome | |||||||
| |||||||
Microbiota | x | x | x | x | x | x | x |
Microbiome |